PMC:7441788 / 41857-42027
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T175 | 140-148 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T304 | 49-50 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T421 | 13-15 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T422 | 51-60 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T252 | 13-15 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T253 | 51-60 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T157 | 140-148 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T285 | 0-170 | Sentence | denotes | Furthermore, CQ/HCQ alone or in combination with a macrolide induced high rate of adverse effects, especially prolonged QTc, in the use for COVID-19 treatment [61,68,69]. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1514 | 13-19 | Chemical | denotes | CQ/HCQ | |
| 1515 | 51-60 | Chemical | denotes | macrolide | MESH:D018942 |
| 1531 | 140-148 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 690 | 16-19 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T167 | 140-148 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 690 | 16-19 | Chemical | denotes | HCQ | MESH:D006886 |
| 1515 | 62-71 | Chemical | denotes | nduced hi | MESH:D018942 |
| 1531 | 151-159 | Disease | denotes | eatment | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T285 | 0-170 | Sentence | denotes | Furthermore, CQ/HCQ alone or in combination with a macrolide induced high rate of adverse effects, especially prolonged QTc, in the use for COVID-19 treatment [61,68,69]. |